The LNP-mRNA modality is a novel approach that uses lipid nanoparticles to deliver messenger RNA into cells. The mRNA acts as ...

Discover the advantages of needle-free vaccines and which companies are developing their own promising delivery solutions in ...

The proposed guidance aims to provide a framework for the approval of personalised mRNA-based cancer vaccines.

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT), a commercial-stage biotechnology company with a market capitalization of $428 million specializing in mRNA therapeutics and vaccines, stands at a ...

Asked whether his bill would similarly ban non-mRNA vaccines for COVID-19, Shippy told the Statesman he did not know. “There ...

Q&A: From people avoiding wild birds to farmers protecting their animals, Kent State epidemiologist Dr. Tara Smith shares ...

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

mRNA vaccines provide an excellent safety profile owing to their inability to integrate into the host genome and their short persistence in the body. Owing to these and other facts, mRNA ...

Moderna is set to receive $590m in funding from the HHS to expedite the development of mRNA-based pandemic influenza vaccines ...

Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an mRNA-based bird flu vaccine, health officials said.

A new class of lipids developed by Penn Engineers improve the rates at which lipid nanoparticles (LNPs) successfully deliver ...

Robert F. Kennedy Jr. spent 2 days this week insisting to senators that he's not anti-vaccine. He said that he instead ...